Anti-HGFR / c-Met Reference Antibody (telisotuzumab vedotin)
Produktgrößen
100 ug
£635,00
CHB249-100UG
1 mg
£2295,00
CHB249-1MG
Über dieses Produkt
- SKU:
- CHB249
- Zusätzliche Namen:
- IgG1|telisotuzumab vedotin
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- Buffer:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Klonalität:
- Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Telisotuzumab vedotin is an ADC consisting of a cMET-directed antibody and Monomethyl auristatin E (MMAE) that has recently obtained the breakthrough therapy designation (BTD) for the treatment of patients with c-Met overexpression, advanced/metastatic wild-type (WT) epithelial growth factor receptor (EGFR) non-squamous non-small cell lung cancer (sqNSCLC) that progressed during or after platinum-based chemotherapy.
- Formulierung:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Immunogen:
- HGFR / c-Met
- Isotyp:
- IgG1
- Physischer Zustand:
- Lyophilized
- Reinheit:
- >90%
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Spezifität:
- HGFR / c-Met
- Lagerbedingungen:
- -70[o]C Avoid freeze/thaw cycles., 2-8[o]C
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:CHB249